New Industries Bio obtains medical device registrations

Shenzhen New Industries Biomedical Engineering Co., Ltd. has announced the receipt of three medical device registration certificates from the Guangdong Provincial Drug Administration. The approvals cover a range of diagnostic products, including an assay kit for tissue polypeptide antigen (TPA), an assay kit for aspartate aminotransferase isoenzyme, and a fully automated biochemical analyzer (Biossays C10). The TPA kit, used for monitoring lung cancer, is valid until June 30, 2030. The enzyme assay, used for liver disease, is valid until June 30, 2030. The Biossays C10 analyzer, for comprehensive biochemical analysis, is valid until July 3, 2030. The company says this is a positive development and the expansion of products will have a positive influence on company development.